1.  Passed U.S. FDA inspection.

2.  Passed TFDA inspection.

3.  Granted approval for first U.S. FDA ANDA product – Repaglinide Tablets, USP. 

4.  Passed U.S. Pre-Approval Inspection (PAI) for two ANDA products.

• Syngen Biotech, Inc., a subsidiary of SCP, listed as an Over-the-Counter (OTC) company.

1. Passed U.S. FDA inspection – API facility.

2. Filed a vertically integrated (API & FDF) U.S. ANDA for an orphan drug.

• Passed Korea Food and Drug Administration (KFDA) inspection.

1. Awarded ISO14001 and OHSAS18001 – the Dual-System International Qualification.

2. Acquired Multipower Enterprise Corp.

3. Established in Jiang-Su Standard Chem. & Pharm. Co., Ltd.

1. Passed Taiwan-FDA PIC/S GMP criterion. (2009-1)

2. Passed Australia TGA inspection – API facility.

3. Acquired Souriree Biotech Pharmaceutical Co., Ltd.

4. Established Standard Pharmaceutical Co., Ltd. (Samoa) and Standard Chem. and Pharm. Philippines, Inc.

(2009-1)

• Obtained an accreditation certificate of Foreign Drug Manufacturer (Japan).

1. Awarded "The Best Industrial Learning-Net in Enterprise" -Taiwan E-learning & Digital Archives Program – e-Learning Quality Certification Center.

2. Granted exclusive Taiwan distribution rights for four international health-care brands –   "Natural Life", "Nature Way", "VSM", and "Weider".

1. Established Standard Nutrition Corp. and obtained exclusive Taiwan distribution rights for GNC.

2. Passed Korea FDA inspection.

3. Formally established SCP’s U.S. ANDA international strategy.

1. Expanded SCP’s facilities: The largest liquid/cream plant in Taiwan.

2. Established Standard R&D Center.

3. Passed TFDA GMP inspection – Food Plant.

4. Passed the third stage of cGMP evaluation, including cGMP validation and qualification. (2004-1)

5. Passed South Africa Medicines Control Council (MCC) evaluation.

 (2004-1)

1. Passed GMP inspection – API Plant.

2. Corporate Investment: Kaoh Sheng Pharmaceutical Co., Ltd., National Taiwan University Innovation Incubator Co., Ltd., and National Chen Kung University Venture Capital Co., Ltd.

1. Passed the second stage of cGMP inspection.

2. Invest in Syn-Tech Chem. & Pharm. Co., Ltd.

• Passed the first stage of cGMP Inspection.

1. First Taiwanese Pharmaceutical Company to pass U.S. FDA inspection.

2. Invested in Sun-You Biotech Pharm. Co., Ltd. and Inforight Technology Co., Ltd.

• Invest in Advpharma Inc. and Zhongshan Venture Capital Co., Ltd.

1. First Taiwanese Pharmaceutical Company to passed ISO9001 international quality certification. 

2. Invested in Syngen Biotech. Co., Ltd. and Chia Sheng Investment Co., Ltd.

1. Factory expansion: Food Plant.

2. Started Special Preparation Plant.

• SCP’s IPO (Stock Code 1720)

1. Approved to list as a public company by the Securities and Futures Commission, Ministry of Finance.

2. Expanded facilities – Organic Synthesis Plant, Pharmaceutical Plant, and scientific traditional Chinese medicine Plant.

3. Established Stason Pharmaceuticals, Inc. in California, US.

• Cooperate with Rhône-Poulenc Rorer, Inc.

1. Passed GMP inspection for veterinarian drugs.

2. Expanded facilities: Standard Plant 2.

• Officially certified as a GMP comprehensive pharmaceutical company.

• Established Syn-Tech Chem. & Pharm. Co., Ltd

• Founded Standard Chem. & Pharm. Co., Ltd.